Facebook Linkedin Twitter Youtube

GBT’s CIP Patent Application of 3D, Multiplanar Photonic Microchips Was Approved for Fast Track

GBT's CIP Patent Application of 3D, Multiplanar Photonic Microchips Was Approved for Fast Track

The CIP (Continuation in Part) patent application protects architecture and manufacturing technologies for Photonic, 3D, Multi-Planar integrated circuit technology

SAN DIEGO, May 01, 2023 (GLOBE NEWSWIRE) — GBT Technologies Inc. ( OTC PINK: GTCH ) (“GBT” or the “Company”), announces that its continuation-in-part (CIP) patent application covering its photonic, 3D, Multi-Planar, integrated circuits design and manufacturing architecture, was approved for Fast Track processing by the United States Patent and Trademark Office. GBT filed for expedited processing to prioritize the photonic CIP application for faster examination, which will allow for a final disposition within approximately twelve months.

Picture of admin

admin

Leave a Replay

Related Posts

Categories

Sign up for our Newsletter

if you want to keep…. to our newsletter or follow our social media

Popular links

Products & Solutions

Follow GBTTI

DISCLAIMER: Certain statements contained in this website may constitute forward-looking statements Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors. The forward-looking statements included in this website represent the Company’s views as of the date of this release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the release.